BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17687532)

  • 1. [Intensive blood pressure reduction in patients with increased cardiovascular risk with high-dose combination therapy of 160 mg valsartan plus 25 mg hydrochlorothiazide. Results of the MACHT II observational study].
    Schühlen H; Abts M; Kastrati D
    Herz; 2007 Aug; 32(5):419-25. PubMed ID: 17687532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
    Calhoun DA; Glazer RD; Pettyjohn FS; Coenen PD; Zhao Y; Grosso A
    Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.
    Lacourcière Y; Wright JT; Samuel R; Zappe D; Purkayastha D; Black HR;
    Blood Press Monit; 2009 Jun; 14(3):112-20. PubMed ID: 19384192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antihypertensive effect of valsartan 80 mg and hydrochlorothiazide 12.5 mg evaluated by ambulatory blood pressure monitoring].
    Vaïsse B; Ghobrial H; Vaur L; Poncelet P; Asmar R; Herpin D; Mallion JM
    Arch Mal Coeur Vaiss; 2001 Aug; 94(8):907-12. PubMed ID: 11575229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lowering of blood pressure, blood pressure amplitude and heart rate by treatment with valsartan or valsartan/hydrochlorothiazide. Results of an open observation study of 11,447 hypertensives].
    Weisser B; Vetter H; Mengden T
    Dtsch Med Wochenschr; 2003 Mar; 128(11):541-4. PubMed ID: 12635025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of valsartan, hydrochlorothiazide, and their combination on 24-h ambulatory blood pressure response in elderly patients with systolic hypertension: a ValVET substudy.
    Duprez DA; Weintraub HS; Cushman WC; Purkayastha D; Zappe D; Samuel R; Izzo JL
    Blood Press Monit; 2011 Aug; 16(4):186-96. PubMed ID: 21747241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure control with valsartan and hydrochlorothiazide in clinical practice: the MACHT Observational Study.
    Abts M; Claus V; Lataster M
    Blood Press Suppl; 2006 Feb; 1():27-32. PubMed ID: 16513579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of the combination valsartan/hydrochlorothiazide compared with amlodipine in a mild-to-moderately hypertensive Brazilian population.
    Franco RJ; Goldflus S; McQuitty M; Oigman W;
    Blood Press Suppl; 2003 Dec; 2():41-7. PubMed ID: 14761076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective and safe reduction of blood pressure with the combination of amlodipine 5 mg and valsartan 160 mg in hypertensive patients not controlled by calcium channel blocker monotherapy.
    Brachmann J; Ansari A; Mahla G; Handrock R; Klebs S
    Adv Ther; 2008 May; 25(5):399-411. PubMed ID: 18465097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of supportive measures on drug adherence in patients with essential hypertension treated with valsartan: the randomized, open-label, parallel group study VALIDATE.
    Düsing R; Handrock R; Klebs S; Tousset E; Vrijens B
    J Hypertens; 2009 Apr; 27(4):894-901. PubMed ID: 19300114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reaching the therapeutic goal in hypertension: results from the Canadian valsartan observational study. (Diovantage 4).
    Tardif JC; Curnew GP; Leclerc JM; Rehel B
    Can J Clin Pharmacol; 2008; 15(2):e177-87. PubMed ID: 18515919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time to achieve blood-pressure goal: influence of dose of valsartan monotherapy and valsartan and hydrochlorothiazide combination therapy.
    Weir MR; Levy D; Crikelair N; Rocha R; Meng X; Glazer R
    Am J Hypertens; 2007 Jul; 20(7):807-15. PubMed ID: 17586417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sexual activity in hypertensive men.
    Della Chiesa A; Pfiffner D; Meier B; Hess OM
    J Hum Hypertens; 2003 Aug; 17(8):515-21. PubMed ID: 12874608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fixed-combination of losartan/hydrochlorothiazide 100 mg/25 mg. Tolerability and efficacy on blood pressure measured in the practice and for 24 hours].
    Förster A; Smolka W; Jung C; Bestehorn K
    MMW Fortschr Med; 2007 Sep; 149 Suppl 3():111-8. PubMed ID: 17955788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of manidipine/delapril versus losartan/hydrochlorothiazide fixed combinations in patients with hypertension and diabetes.
    Roca-Cusachs A; Schmieder RE; Triposkiadis F; Wenzel RR; Laurent S; Kohlmann O; Fogari R;
    J Hypertens; 2008 Apr; 26(4):813-8. PubMed ID: 18327093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fixed combination therapy of hypertension: focus on valsartan/hydrochlorothiazide combination (Diovan/HCT).
    Chrysant SG
    Expert Rev Cardiovasc Ther; 2003 Sep; 1(3):335-43. PubMed ID: 15030262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-combi) study.
    Saito I; Saruta T;
    Hypertens Res; 2006 Oct; 29(10):789-96. PubMed ID: 17283866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of valsartan compared with valsartan/hydrochlorothiazide on plasma levels of cellular adhesion molecules: the Val-MARC trial.
    Conen D; Everett BM; Glynn RJ; Ridker PM
    Heart; 2008 Mar; 94(3):e13. PubMed ID: 17923463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aliskiren and valsartan in stage 2 hypertension: subgroup analysis of a randomized, double-blind study.
    Yarows SA; Oparil S; Patel S; Fang H; Zhang J
    Adv Ther; 2008 Dec; 25(12):1288-302. PubMed ID: 19066757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.